Blog

Blue hued illustration of a DNA strand (double helix)

Wall Street Titan Roy J. Bostock Joins GID BIO

LOUISVILLE, Colo., July 28, 2020 — Roy J. Bostock, former Chairman of Yahoo!, Vice Chairman of Delta Airlines and a director of Morgan Stanley, has joined the cellular medicine startup GID BIO…

GID BIO reaches halfway enrollment in cell therapy trial

GID BIO reaches halfway enrollment in randomized double-blinded pivotal Phase III cell therapy trial
FDA-compliant trial addresses treatment gap for regenerative medicine to potentially treat knee osteoarthritis…

Dr. Manish Gupta joins the GIDOA-3 team

Dr. Manish Gupta, an orthopaedic surgeon with a sports medicine focus enters as GID BIO’s newest principal investigator in a pivotal trial of the GID SVF-2…

The FDA approval process and patient safety

In 2017, the Food and Drug Administration gave for-profit stem cell clinics three years to engage the regulatory approval process to establish the safety…

Two new employees join GID BIO team

GID BIO welcomes two new employees to the team as the newest of eight trial sites begin gearing up to enroll patients to participate in…

AdventHealth Orlando joins as newest trial site in pivotal trial

Tariq Awan, DO, a double-certified family and sports medicine physician with a special focus in sports medicine enters as GID BIO’s newest principal investigator in a pivotal Phase III trial evaluating cellular therapy for the treatment…

UC Davis joins as trial site in pivotal trial

Charles De Mesa, DO, MPH, a Northern California practicing specialist in anesthesiology and pain medicine, physical medicine and rehabilitation and musculoskeletal pain medicine is GID Bio’s newest principal investigator in a pivotal trial…

error: Content is protected !!
Skip to content